Social isolation also increases the risk of COPD death, underscoring the challenge of managing a demanding chronic illness by ...

Chronic obstructive pulmonary disease has become a major global health concern. According to the World Health Organisation's November 2024 report, COPD remains the world's fourth largest cause of ...

AstraZeneca has reported positive high-level results from the phase 3 MIRANDA trial of tozorakimab, showing a statistically ...

Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million ...

Consuming legumes and soy-based foods may help improve symptoms of chronic obstructive pulmonary disease (COPD) by reducing inflammation and irritation, according to a new study in the March 2026 ...

A new study suggests that simple phone-based coaching can dramatically improve how people with COPD use their inhalers, ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple daily activities feel overwhelming. For people with severe COPD, walking across ...

Nebulisers are often used reactively, meaning they are introduced when symptoms become difficult to control rather than ...

Consuming legumes and soy-based foods may help improve symptoms of chronic obstructive pulmonary disease (COPD) by reducing ...

Third positive pivotal Phase III clinical trial of AstraZeneca’s IL-33-targeting biologic further demonstrates its benefits in COPD Positive high-level results from the pivotal Phase III MIRANDA trial ...

A study shows higher isoflavone intake from soy and legumes is linked to reduced COPD symptoms, including less coughing, ...